Description
Glimepirid-TEVA Tablets 2 mg. №30
Ingredients:
Each tablet contains 2 mg of Glimepiride as the active ingredient. Inactive ingredients include microcrystalline cellulose, povidone, sodium starch glycolate, and magnesium stearate.
Mechanism of Action:
Glimepiride stimulates insulin release from pancreatic beta cells, thereby lowering blood glucose levels in patients with type 2 diabetes mellitus.
Pharmacological Properties:
Glimepiride belongs to the sulfonylurea class of drugs and acts by binding to specific receptors on pancreatic beta cells, leading to increased insulin secretion.
Indications for Use:
Glimepirid-TEVA tablets are indicated for the treatment of type 2 diabetes mellitus to help control blood sugar levels.
Contraindications:
Avoid using Glimepirid-TEVA tablets in patients with type 1 diabetes, diabetic ketoacidosis, or known hypersensitivity to sulfonylureas. Use with caution in individuals with renal or hepatic impairment.
Side Effects:
Common side effects may include hypoglycemia, dizziness, headache, and gastrointestinal disturbances. Rarely, severe allergic reactions or liver problems may occur.
Usage Instructions:
The typical starting dose is 1-2 mg once daily with breakfast or the first main meal. Adjustments to the dosage should be based on individual blood glucose levels, with a maximum daily dose of 8 mg.
Benefits Compared to Analogues:
Glimepirid-TEVA tablets offer effective blood sugar control with a low risk of hypoglycemia compared to some other antidiabetic medications.
Suitable Patient Groups:
Glimepirid-TEVA tablets can be used in adult patients with type 2 diabetes, including elderly individuals. Use in children should be carefully monitored by a healthcare provider.
Storage and Shelf Life:
Store Glimepirid-TEVA tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use after the stated shelf life.
Packaging Description:
Glimepirid-TEVA tablets are supplied in blister packs of 30 tablets each, with clear labeling of the product name, strength, and expiration date.
Scientific Evidence:
Studies have demonstrated the efficacy of Glimepiride in lowering blood glucose levels and improving glycemic control in patients with type 2 diabetes mellitus.
Clinical trials have shown a reduction in HbA1c levels with the use of Glimepirid-TEVA tablets, indicating improved long-term blood sugar management.
Additional Information:
For optimal results, it is essential to maintain a healthy diet and exercise regimen while taking Glimepirid-TEVA tablets.
Consult your healthcare provider for personalized guidance on diabetes management and medication usage.
